Evidence map›Paper›PMID 41157119›Full record

ReviewMolecules (Basel, Switzerland)2025

The Perspectives of Combining Antibiotics with Saponins-Herbal Excipients.

Aleksandra Makiej, Wojciech Smułek, Ewa Kaczorek

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aleksandra MakiejInstitute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, PL-60965 Poznan, Poland.ORCID 0000-0002-2816-9030
Wojciech SmułekInstitute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, PL-60965 Poznan, Poland.ORCID 0000-0001-5377-9933
Ewa KaczorekInstitute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, PL-60965 Poznan, Poland.ORCID 0000-0003-2478-4738

Funding

National Science Centre 2020/39/B/NZ9/03196
6 · The paper itself

Abstract

The overuse of antibiotics in human and veterinary medicine has contributed significantly to their persistent presence in the environment, creating conditions that promote the spread of antimicrobial resistance (AMR). In this context, innovative approaches that reduce antibiotic doses without compromising therapeutic efficacy are urgently needed. This review explores the emerging role of plant-derived secondary metabolites, particularly saponins, as bioactive excipients capable of enhancing antibiotic activity through synergistic mechanisms. By improving membrane permeability, inhibiting resistance pathways, and modulating host responses, these natural adjuvants may allow for lower antibiotic concentrations in clinical treatments, ultimately reducing pharmaceutical residues entering the environment. We discuss the potential of such combined therapies not only to mitigate the evolution and dissemination of AMR in natural microbial communities but also to provide more sustainable, biodegradable, and ecologically safer alternatives to synthetic formulation agents. Plant-derived compounds, inherently shaped by co-evolution with microbes, offer a dynamic and adaptive molecular diversity that may be less prone to long-term microbial resistance. In addition to reviewing current knowledge, this article highlights the environmental and public health implications of integrating phytochemical excipients into antibiotic regimens, and calls for further interdisciplinary efforts to evaluate their safety, efficacy, and role in shaping future antimicrobial stewardship.

Indexed as

Anti-Bacterial AgentsExcipientsSaponinsAnimalsHumansAnti-Bacterial AgentsExcipientsSaponinsAntibiotic Resistance MitigationEco-Friendly Therapeutic ExcipientsHuman Environmental HealthPlant-Derived BioenhancerssaponinsSustainable Antimicrobial Strategies

Identifiers

PMID41157119
PMCPMC12566456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.